A hybrid quantum-AI model just beat classical computers at drug design
a dtu and orca computing hybrid model generated more successful peptides than classical methods, proving quantum can improve drug discovery for rare diseases.
a team from the technical university of denmark used a printer-sized quantum computer from orca computing to boost a generative ai model for predicting proteins, resulting in more successful peptides than classical counterparts. the hybrid approach excelled specifically where training data was sparse, addressing a critical gap in developing therapies for non-western populations. while current quantum hardware lacks the power for full-scale antibody design, this experiment provides a concrete near-term commercial application for the technology.